AMIT PATEL

Profile

First Name

: AMIT

Middle Name

:

Last Name

: PATEL

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2026-05-26 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2026-04-28 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2026-04-23 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2026-03-26 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-24 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2025-06-16 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2025-06-16 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2025-01-27 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-12-11 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-09-12 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-11 
D
 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-30 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2023-11-28 
D
RESIDENTIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-11-21 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-28 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-08-29 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-18 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Debt 
2023-03-13 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-07 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-15 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-11-30 
D
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2022-08-19 
D/A
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-08-25 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-08 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-11 
D/A
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-07-30 
D/A
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-07-30 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-15 
D/A
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-08-25 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2021-08-11 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-07 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-14 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-08-25 
D/A
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2020-05-01 
D/A
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2020-05-01 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-24 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-24 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-11 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
D/A
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2018-07-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-09-13 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-21 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-03-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-02-27 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-01-17 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-03-15 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2017-12-15 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-02-15 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2018-01-20 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-29 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-12-01 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2017-11-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-08-31 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-28 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2017-06-29 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-05-05 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-05-08 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-05-02 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-04-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2017-03-23 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-29 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2016-08-06 
D/A
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2015-03-30 
D
BIOTECHNOLOGY 
[9995] 
NO REVENUES 
Equity 
2016-05-18 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-18 
D
OTHER HEALTH CARE 
 
$1 - $1,000,000 
Equity 
2016-02-03 
D
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2015-03-30 
D
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2013-06-13